KELOWNA, BC – Lexaria Bioscience Corp., a global innovator in drug delivery platforms is pleased to announce the engagement of the contract research organization (“CRO”) to execute and report on… Read More
RARITAN, N.J. — Johnson & Johnson announced the permanent Healthcare Common Procedure Coding System (HCPCS) J-code for INLEXZO™ (gemcitabine intravesical system) is now in effect. Adult patients living with certain types… Read More
FRANKLIN LAKES, N.J – BD (Becton, Dickinson and Company), a leading global medical technology company, announced the launch of the BD® Pyxis™ Pro Dispensing Solution and BD® Incada™ Connected Care Platform in Europe. This… Read More
Most lipid nanoparticle (LNP) platforms face the same constraint: they are cleared rapidly by the liver, which makes it hard to deliver nucleic acids to tissues beyond that organ. Targeted LNPs… Read More
Johnson & Johnson presents new data showing high rates of complete skin clearance achieved at Week 24 and Week 52 in ICONIC-ADVANCE 1 and 2 studies Nearly 60% of adolescents treated… Read More
